Nicholson K, Liu W, Fitzpatrick D, et al. Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review. Lancet Healthy Longev. 2024;5(4):e287–96. https://doi.org/10.1016/S2666-7568(24)00007-2.
Formica D, Sultana J, Cutroneo PM, et al. The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Expert Opin Drug Saf. 2018;17(7):681–95. https://doi.org/10.1080/14740338.2018.1491547.
Article CAS PubMed Google Scholar
Carollo M, Boccardi V, Crisafulli S, et al. Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium. Aging Clin Exp Res. 2024;36(1):63. https://doi.org/10.1007/s40520-023-02679-2.
Article PubMed PubMed Central Google Scholar
Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315(7115):1096–9. https://doi.org/10.1136/bmj.315.7115.1096.
Article CAS PubMed PubMed Central Google Scholar
Dalton K, Evrard P, Moriarty F, et al. How are prescribing cascades defined in the literature? A scoping review. Res Social Adm Pharm. 2025. https://doi.org/10.1016/j.sapharm.2025.07.001.
McCarthy LM, Visentin JD, Rochon PA. Assessing the scope and appropriateness of prescribing cascades. J Am Geriatr Soc. 2019;67(5):1023–6. https://doi.org/10.1111/jgs.15800.
Hallyburton A. Diagnostic overshadowing: an evolutionary concept analysis on the misattribution of physical symptoms to pre-existing psychological illnesses. Int J Ment Health Nurs. 2022;31(6):1360–72. https://doi.org/10.1111/inm.13034.
Article PubMed PubMed Central Google Scholar
Trifirò G, Spina E. Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems. Curr Drug Metab. 2011;12(7):611–20. https://doi.org/10.2174/138920011796504473.
Rochon PA, Li J, O’Mahony D, et al. The impact of age, sex, and gender on polypharmacy and potential prescribing cascades: lessons from five databases. J Am Geriatr Soc. 2025;73(2):520–32. https://doi.org/10.1111/jgs.19282.
Doherty AS, Shahid F, Moriarty F, et al. Prescribing cascades in community-dwelling adults: a systematic review. Pharmacol Res Perspect. 2022;10(5):e01008. https://doi.org/10.1002/prp2.1008.
Article PubMed PubMed Central Google Scholar
Daunt R, McGettigan S, Kelly L, Curtin D, O’Mahony D. Detection of potential prescribing cascades in multimorbid older patients hospitalised with acute illness—an observational prospective prevalence study. Drugs Aging. 2025;42(6):535–46. https://doi.org/10.1007/s40266-025-01201-9.
Article PubMed PubMed Central Google Scholar
Gates M, Gates A, Pieper D, et al. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement. BMJ. 2022. https://doi.org/10.1136/bmj-2022-070849.
Article PubMed PubMed Central Google Scholar
Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10. https://doi.org/10.1186/1471-2288-7-10.
Article PubMed PubMed Central Google Scholar
Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. https://doi.org/10.1136/bmj.j4008.
Article PubMed PubMed Central Google Scholar
JBI critical appraisal tools | JBI. https://jbi.global/critical-appraisal-tools. Accessed 4 Sept 2025.
Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132–40. https://doi.org/10.1097/XEB.0000000000000055.
Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Umbrella reviews (2020). Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis. 9. Umbrella reviews. https://jbi-global-wiki.refined.site/space/MANUAL/355829653/9.+Umbrella+reviews. Accessed 1 Apr 2025.
Morris EJ, Hollmann J, Hofer AK, et al. Evaluating the use of prescription sequence symmetry analysis as a pharmacovigilance tool: a scoping review. Res Soc Adm Pharm. 2022;18(7):3079–93. https://doi.org/10.1016/j.sapharm.2021.08.003.
Chen Z, Liu Z, Zeng L, Huang L, Zhang L. Research on prescribing cascades: a scoping review. Front Pharmacol. 2023;14:1147921. https://doi.org/10.3389/fphar.2023.1147921.
Article CAS PubMed PubMed Central Google Scholar
Adrien O, Mohammad AK, Hugtenburg JG, et al. Prescribing cascades with recommendations to prevent or reverse them: a systematic review. Drugs Aging. 2023;40(12):1085–100. https://doi.org/10.1007/s40266-023-01072-y.
Article PubMed PubMed Central Google Scholar
Doherty A, Moriarty F, Boland F, et al. Prescribing cascades in community-dwelling adults: protocol for a systematic review. HRB Open Res. 2021;4:72. https://doi.org/10.12688/hrbopenres.13345.2.
Article PubMed PubMed Central Google Scholar
Shahid F, Doherty A, Wallace E, Schmiedl S, Alexander GC, Dreischulte T. Prescribing cascades in ambulatory care: a structured synthesis of evidence. Pharmacotherapy. 2024;44(1):87–96. https://doi.org/10.1002/phar.2880.
Clifford GM, Farmer RDT. Drug or symptom-induced depression in men treated with alpha 1-blockers for benign prostatic hyperplasia? A nested case–control study. Pharmacoepidemiol Drug Saf. 2002;11(1):55–61. https://doi.org/10.1002/pds.671.
Article CAS PubMed Google Scholar
Dyson TE, Cantrell MA, Lund BC. Lack of association between 5α-reductase inhibitors and depression. J Urol. 2020;204(4):793–8. https://doi.org/10.1097/JU.0000000000001079.
Fox CW, Khaw CL, Gerke AK, Lund BC. Montelukast and neuropsychiatric events—a sequence symmetry analysis. J Asthma. 2022;59(12):2360–6. https://doi.org/10.1080/02770903.2021.2018705.
Hagberg KW, Divan HA, Nickel JC, Jick SS. Risk of incident antidepressant-treated depression associated with use of 5α-reductase inhibitors compared with use of α-blockers in men with benign prostatic hyperplasia: a population-based study using the Clinical Practice Research Datalink. Pharmacotherapy. 2017;37(5):517–27. https://doi.org/10.1002/phar.1925.
Article CAS PubMed Google Scholar
Hersom K, Neary MP, Levaux HP, Klaskala W, Strauss JS. Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis. J Am Acad Dermatol. 2003;49(3):424–32. https://doi.org/10.1067/s0190-9622(03)02087-5.
Hoang T, Liu J, Roughead E, Pratt N, Li J. Supervised signal detection for adverse drug reactions in medication dispensing data. Comput Methods Programs Biomed. 2018;161:25–38. https://doi.org/10.1016/j.cmpb.2018.03.021.
Idema D, Wang Y, Biehl M, Horvatovich P, Hak E. Effect estimate comparison between the prescription sequence symmetry analysis (PSSA) and parallel group study designs: a systematic review. PLoS ONE. 2025. https://doi.org/10.1371/journal.pone.0208389.
Article PubMed PubMed Central Google Scholar
Kröger E, Van Marum R, Souverein P, Carmichael PH, Egberts T. Treatment with rivastigmine or galantamine and risk of urinary incontinence: results from a Dutch database study. Pharmacoepidemiol Drug Saf. 2015;24(3):276–85. https://doi.org/10.1002/pds.3741.
Lai ECC, Hsieh CY, Wong MB, et al. Comparative risk of oral ulcerations among antipsychotics users—population-based retrospective cohort study. Pharmacoepidemiol Drug Saf. 2016;25(2):123–32. https://doi.org/10.1002/pds.3903.
Comments (0)